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http://www.rbej.com/content/10/1/86RESEARCH Open AccessNF kappaB expression increases and CFTR and
MUC1 expression decreases in the endometrium
of infertile patients with hydrosalpinx:
a comparative study
Yong Song1, Qiushi Wang1, Wei Huang1*, Li Xiao1, Licong Shen1 and Wenming Xu2Abstract
Background: Hydrosalpinx are associated with infertility, due to reduced rates of implantation and increased
abortion rates. The aims of this study were to investigate the expression of cystic fibrosis transmembrane
conductance regulator (CFTR), nuclear factor kappa B (NF KappaB) and mucin-1 (MUC-1), and analyze the
correlation between the expression of CFTR and NF KappaB or MUC1, in the endometrium of infertile women with
and without hydrosalpinx.
Methods: Thirty-one infertile women with laparoscopy-confirmed unilateral or bilateral hydrosalpinx and 20 infertile
women without hydrosalpinx or pelvic inflammatory disease (control group) were recruited. Endometrial biopsy
samples were collected and the expression of CFTR, NF KappaB and MUC1 were analyzed using
immunohistochemistry and quantitative real-time PCR.
Results: CFTR, NF KappaB and MUC1 mRNA and protein expression tended to increase in the secretory phase
compared to the proliferative phase in both groups; however, these differences were not significantly different. The
endometrium of infertile patients with hydrosalpinx had significantly higher NF KappaB mRNA and protein
expression, and significantly lower CFTR and MUC1 mRNA and protein expression, compared to control infertile
patients. A positive correlation was observed between CFTR and MUC1 mRNA expression (r = 0.65, P < 0.05); a
negative correlation was observed between CFTR mRNA and NF KappaB mRNA expression (r = −0.59, P < 0.05).
Conclusions: Increased NF KappaB expression and decreased CFTR and MUC1 expression in the endometrium of
infertile patients with hydrosalpinx reinforce the involvement of a molecular mechanism in the regulation of
endometrial receptivity.
Keywords: Cystic fibrosis transmembrane conductance regulator, Endometrium, Hydrosalpinx, Mucin-1, Nuclear
factor kappa BBackground
Hydrosalpinx is a common disorder characterized by a dis-
tally-blocked, dilated, fluid-filled fallopian tube. The rate of
occurrence ranges from 10% to 13% when diagnosed by
ultrasound, and up to 30% when diagnosed by hysterosalpin-
gography, laparoscopy or laparotomy [1]. Evidence from two
meta-analyses suggests that hydrosalpinges are associated* Correspondence: weihuang64@163.com
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reproduction in any medium, provided the orwith reduced rates of implantation and pregnancy, and
increased abortion rates [2,3]. Laparoscopic salpingectomy of
hydrosalpinges prior to in vitro fertilization (IVF) can im-
prove the odds of clinical pregnancy and ongoing pregnancy
in women undergoing IVF [4]. However, the exact mechan-
isms which lead to reduced fertility in women with hydrosal-
pinges are unclear: various theories have been proposed,
including increased uterine peristalsis, the mechanical barrier
created by intrauterine accumulation of refluxed fluid, the
embryotoxicity of hydrosalpinx fluid or altered endometrial
receptivity [5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lator (CFTR) is a Cl2 channel expressed in the epithelial
cells of a wide variety of tissues, including the human
endometrium. CFTR is regulated by cAMP-dependent
phosphorylation, and its expression in the human endo-
metrium has been reported to be regulated by sex-
hormones such as estrogen and progestogen [6]. As an
anion channel, CFTR may play a key role in the active
secretion of electrolytes and fluid by the epithelial cells
of the endometrium, thus providing the optimal uterine
environment necessary for blastocyst implantation. Re-
cently, CFTR has been reported to be involved in the
regulation of other proteins in some human cells, includ-
ing nuclear factor kappa B (NF KappaB) and mucin-1
(MUC1) [7,8]. NF KappaB is a large family of transcrip-
tion factors, whose expression in the human endomet-
rium varies throughout the menstrual cycle [9]. MUC1
is a highly glycosylated macromolecule expressed on the
cell surface which is an important endometrial receptiv-
ity factor [10].
Although the patterns of expression of CFTR and NF
KappaB have been reported in the endometrium, the
role of these factors in the pathogenesis of hydrosalpinx
and the relationship between these factors, hydrosalpinx
and infertility are poorly characterized. Therefore, we
examined the expression of CFTR, NF KappaB and
MUC1 in endometrial tissues collected from infertile
patients with or without hydrosalpinx, and analyzed the
relationship between CFTR and NF KappaB or MUC1




The study was approved by the Medical Research Re-
view Board of West China Second University Hospital of
Sichuan University, and written informed consent was
obtained from all of the patients included in the study.
From September 2010 to April 2011, 51 infertile women
were recruited. All patients underwent comprehensive
fertility investigations, including hormone analysis,
documentation of ovulation, transvaginal ultrasound,
hysterosalpingography, laparoscopy and hysteroscopy, in
order to exclude patients with other disorders that may
cause infertility, such as ovarian disorders, endometri-
osis, adenomyosis, endometrial lesions, tumors or otherTable 1 Clinical information of the infertile patients with or w
Hydrosalpinx group
Patients(n) 31
Age (yrs, range) 29.21±4.79(23–39)
Infertility duration (yrs) 4.80±3.68
BMI 20.95±3.57pelvic inflammatory diseases. A total of 31/51 women
were diagnosed with hydrosalpinx by hysterosalpingo-
graphy followed by laparoscopic confirmation, 20/51
patients without hydrosalpinx were included as controls.
All of the patients were aged between 20 and 40 years,
with regular menstrual cycles, no history or presence of
any autoimmune disease, and had not received hormo-
nal treatment during the three months before surgery
(at least). There were no significant differences in the
mean age, duration of infertility and body mass index
(BMI) of the two groups (Table 1). The endometrial tis-
sues were obtained from the uterine cavity during sur-
gery. The tissues were divided into three pieces, one
piece was immediately fixed in 10% buffered formalin
and paraffin embedded for immunohistochemistry, one
was placed into an microfuge tube and stored at −80°C
for PCR analysis, and the other was fixed in 4% formal-
dehyde, paraffin embedded, serial 4 mm sections were
prepared, stained with hematoxylin and eosin (H&E),
and subjected to routine histological examination.
The menstrual phase was based on the last menstrual
date, followed by histological confirmation, according to
the criteria of Noyes et al. [11]. In the hydrosalpinx
group, 20 patients were in the proliferative phase of the
menstrual cycle and 11 in the secretory phase; whereas
12 women in the control group were in the proliferative
phase and 8 in the secretory phase.
RNA isolation, cDNA synthesis and real-time PCR
Total RNA was extracted using TRIzol reagent, according
to the manufacturer’s protocol (Life Technologies Inc.,
Carlsbad, CA, USA); the nucleotide: protein ratios (A260:
A280) of all samples were within the acceptable boundar-
ies of 1.8 and 2.1. First strand complementary DNA
(cDNA) synthesis was performed using the PrimeScript
RT reagent kit (TaKaRa Biotechnology, Dalian, China) fol-
lowing the manufacturer’s protocol at 37°C for 30 min fol-
lowed by deactivation at 85°C for 8 sec. Polymerase chain
reaction (PCR) was performed using the following primers




TCCATCACTACTTCT-30; MUC1, forward 50-TGCCT
TGGCTGTCTGTCAGT-30, reverse 50-GTAGGTATCCC
GGGCTGGAA-30; NF KappaB, forward 50-CTGAACCAithout hydrosalpinx
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CGCAAT-30. Each well of the PCR plate contained 5 μl
EvaGreen Supermix (Bio-Rad Laboratories, Hercules, CA,
USA), 1 μl of each primer (10 μmol/L) and 3 μl cDNA.
Amplification was performed over 39 cycles of 95°C for
30 s, 95°C for 5 s and 60°C for 10 s using the CFX96 Real-
Time System (Bio-Rad Laboratories). All experiments were
performed in triplicate. The threshold cycle values were
normalized against the threshold value of human GADPH
and the results were expressed as the mean ± SEM.
Immunohistochemistry
Immunohistochemical staining was performed using
rabbit polyclonal anti–CFTR (ACL-006; Alomone Labs,
Israel), rabbit polyclonal anti-NF KappaB p65 (bs-0465R;
Bioss, Beijing, China) and mouse monoclonal anti-
MUC1 (sc-7313; Santa Cruz Biotechnology, CA, USA)
as primary antibodies. Briefly, serial sections were pre-
pared, mounted onto gelatin-coated slides, dried over-
night at 37°C, deparaffinized in xylene and rehydrated
through a graded ethanol series. In order to retrieve the
epitopes, the slides were immersed in a bath of pH 6.0
citrate antigen retrieval buffer for 10 min at 120°C. After
cooling, the sections were incubated with 3% H2O2 for
10 min to block endogenous peroxidase activity, blocked
with 10% normal goat serum for 15–30 min, then incu-
bated with the primary antibodies (CFTR 1:200; NF Kap-
paB 1:300; MUC1 1:300) at 4°C overnight. The
secondary biotinylated antibody and streptavidin-
peroxidase conjugate were applied in accordance with
the manufacturer’s instructions (Beijing Zhongshan Bio-
tech Company, Beijing, China), staining was visualized
using diaminobenzidine solution, and then the sections
were counterstained with hematoxylin and mounted.
Colorectal carcinoma tissues were used as a positive
control for NF KappaB and MUC1; rat lung tissues were
used as a positive control for CFTR. Negative controls
were performed by incubating the sections with PBS in-
stead of the primary antibodies.
Negative staining was defined as the absence of an
immunoreactive signal in either the stromal or glandular
cells. Positive staining was defined as immunoreactive
signal in the stromal or glandular cells. The H-Score
[12] was used to assess glandular and stromal cell stain-
ing intensity and was calculated using the following
equation: H-Score = Σ Pi (i + 1), where i is the intensity
of staining (1, weak; 2, moderate; 3, strong) and Pi repre-
sents the percentage of cells stained (0–100%). The H-
scores range from 0 to 4.
Statistical analysis
Statistical analysis was performed using SPSS version 18.0
(SPSS, Chicago, IL, USA). The Student’s t-test was used to
compare mRNA expression levels in the hydrosalpinxgroup and control group, and the number of cases in the
proliferative phase and secretory phase in each group. The
Mann–Whitney U-test was used to compare the immuno-
histochemical H-scores. Spearman’s correlation analysis
was used to assess the correlations between CFTR and NF
KappaB or MUC1 mRNA expression. P values less than
0.05 were considered statistically significant.
Results
Expression of CFTR, NF KappaB and MUC1 in the
endometrium of infertile patients with or without
hydrosalpinx
As shown in Figure 1, CFTR was mainly expressed at
the apical membrane of the glandular and luminal epi-
thelial cells of the endometrium, and was almost absent
in stromal cells. Noticeable expression of NF KappaB
was observed in the cytoplasm of the glandular and lu-
minal epithelial cells, with mild expression detected in
the stromal cells of the endometrium. MUC1 was
expressed at high levels in the membrane and cytoplasm
of the glandular and luminal epithelial cells, but was not
expressed in stromal cells.
Compared to the control patients, the endometrium of
the infertile patients with hydrosalpinx had a signifi-
cantly increased NF KappaB H-score (3.6 ± 0.5 vs. 3.0 ±
0.8; P = 0.03). The expression of CFTR and MUC1 in
patients with hydrosalpinx were significantly lower than
the control patients (2.3 ± 0.5 vs. 3.0 ± 0.7 and 2.9 ± 0.4
vs. 3.7 ± 0.5 respectively; P = 0.0001).
Quantitative real-time PCR analysis was also per-
formed on the endometrial tissues collected from the
hydrosalpinx group and the control group. In agreement
with the immunohistochemistry results, MUC1 mRNA
and CFTR mRNA were expressed at significantly lower
levels in the hydrosalpinx group than the control group,
while NF KappaB mRNA was expressed at significantly
higher levels in the hydrosalpinx group than the control
group (all P < 0.01, Figure 2).
A trend towards increased CFTR, NF KappaB and
MUC1 H-scores were observed from the proliferative
phase to the secretory phase in both groups (Table 2).
Similarly, the expression levels of CFTR, MUC1 and NF-
kB mRNA were lower in the proliferative phase and
higher in the secretory phase (Figure 3); however, these
differences were not statistically significant (P > 0.05).
Relationship between the expression of CFTR, NF KappaB
and MUC1 in the endometrium of infertile patients with
or without hydrosalpinx
Spearman’s correlation analysis demonstrated that a
positive correlation existed between the expression of
CFTR and MUC1 mRNA in the entire cohort of infertile
patients with and without hydrosalpinx (r = 0.65, P <
0.05). Additionally, a negative correlation was observed
Figure 1 CFTR, NF KappaB and MUC1 immunohistochemical staining in the endometrium. Representative images of positive control CFTR,
NF KappaB and MUC1 immunostaining (A-C) and negative control CFTR, NF KappaB and MUC1 immunostaining (D-F), respectively. CFTR, NF
KappaB and MUC1 immunostaining in the endometrium of control infertile patients without a hydrosalpinx (G–L) and infertile patients with a
hydrosalpinx (M–R). Endometrial tissues in the proliferative (D–I, M–O) and secretory (J–L, P–R) phases are shown for both groups; ×400
magnification.
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pression in the entire cohort of infertile patients with
and without hydrosalpinx (r = −0.59, P < 0.05).
Discussion
Implantation of the embryo is an initial step in the estab-
lishment of a successful pregnancy, and involves acomplex sequence of signaling events. A large number of
molecular mediators have been identified and postulated
to be involved in this early fetal–maternal interaction, in-
cluding a variety of inter-related molecules such as adhe-
sion molecules, cytokines, growth factors and lipids [13].
Several benign gynecological disorders, including hydro-
salpinx, may hinder implantation by influencing
**P<0.01, ***P<0.001  
Figure 2 Real-time PCR analysis of CFTR, MUC1 and NF kappa B
mRNA in the endometrium with or without hydrosalpinx. MUC1
mRNA and CFTR mRNA were expressed at significantly lower levels
in the hydrosalpinx group than the control group, while NF KappaB
mRNA was expressed at significantly higher levels in the
hydrosalpinx group than the control group.
Figure 3 Comparison of CFTR, NF kappa B, and MUC1 mRNA
expression in endometrial tissues in the proliferative phase
versus in the secretory phase of infertile women with
hydrosalpinx and those without hydrosalpinx. The expression
levels of CFTR, MUC1 and NF kappa B mRNA were lower in the
proliferative phase and higher in the secretory phase, but these
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the salpinx before IVF can increase the success rate of IVF
[4]. The presence of hydrosalpinx may affect the expres-
sion of molecules which mediate endometrial receptivity
in the endometrium, such as αvβ3 integrin and leukemia
inhibitory factor (LIF) [14]; however, the exact mechan-
isms by which a hydrosalpinx affects implantation are un-
clear and require further research.
CFTR plays an important role in the implantation
process [6]. As an apical Cl− channel, CFTR regulates
Cl− secretion and thus fluid volume. Additionally, CFTR
is co-expressed with the epithelial NaC channel (ENaC),
which has been proposed to be the major mechanism
regulating uterine fluid absorption. Upregulation of
ENaC and downregulation of CFTR have been observed
in the endometrial epithelia of mice during preimplanta-
tion, providing a molecular basis for the ‘closure’ of the
uterine lumen observed on the day of implantation.
Interestingly, in this study we observed that theTable 2 CFTR, NF KappaB and MUC1 protein expression
in endometrial tissues in the proliferative phase and
secretory phase from infertile patients with or without
hydrosalpinx
Hydrosalpinx group Control group P value
PP SP PP SP
CFTR 2.8±0.5 3.3±0.6 2.3±0.4 2.3±0.6 ns
NFkappaB 2.9±0.7 3.2±0.5 3.0±0.9 3.6±0.6 ns
MUC1 3.6±0.5 3.8±0.5 2.8±0.4 3.2±0.5 ns
All immunohistochemical staining scores are presented as H-score.
*Mann–Whitney Test. PP, proliferative phase; SP, the secretory phase.
differences were not statistically significant. PP, proliferative phase;
SP, the secretory phase.expression level of CFTR was significantly lower in the
endometrium of infertile patients with hydrosalpinx.
However, a previous study conducted in mice suggested
that LPS produced by uterine infection with C. tracho-
matis induced upregulation of CFTR and abnormal fluid
accumulation in the mouse uterus at diestrus [15].
There are several reasons which may lead to the incon-
sistencies between these studies. Firstly, different species
were examined in each study. Secondly, in this study
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from mice, and CFTR expression was analyzed only 24
hours after C. trachomatis LPS inoculation; therefore, it
is probable that the uteri were still in the acute inflam-
matory phase. In contrast, the patients in our study had
a history of hydrosalpinx ranging from 1 to 13 years;
therefore, the disease had progressed to the chronic
phase. It is possible that the decreased CFTR expression
observed in infertile patients with hydrosalpinx in our
study may be the result of a compensatory effect. Fur-
ther studies are required to determine the expression
and regulation of CFTR in the endometrium of infertile
patients with hydrosalpinx.
NF KappaB is a family of transcription factors involved
inflammatory and immune responses, which control
cytokine and adhesion molecule gene expression in a
variety of cell types, including the human endometrium.
Similarly to CFTR, a non-significant trend toward
increased NF KappaB mRNA and protein were observed
throughout the menstrual cycle in this study. However,
NF KappaB expression was mainly distributed in the
cytoplasm. Nuclear expression of NF KappaB is asso-
ciated with the activation of NF KappaB in pathological
processes [16]. However, nuclear translocation of NF
KappaB is a transient, rapid event. It is possible that the
tissue sampling method or immunohistochemical tech-
niques used in this study were not suitable for detecting
subtle changes in NF KappaB activation; therefore, the
lack of detectable nuclear NF KappaB expression in this
study may not reflect a lack of NF KappaB activation [9].
More importantly, our study demonstrates that NF
KappaB mRNA and protein expression are increased in
the endometrium of infertile patients with hydrosalpinx,
which has not been previously described. Hydrosalpinx is
the result of chronic pelvic inflammatory disease and is
characterized by fluid accumulation in the fallopian tube.
NF KappaB is one of the most important regulators of
pro-inflammatory gene expression, and the synthesis of a
variety of cytokines, such as interleukia ( IL)-6 and LIF, are
mediated by NF KappaB [17-19]. The presence of high
concentrations of cytokines, including (IL)-8, tumor ne-
crosis factor (TNF)-α and LIF, have been detected in
hydrosalpingeal fluid [18]. Hydrosalpingeal fluid can flow
into the uterine cavity, where the abundant cytokines may
stimulate production of NF KappaB in the endometrium.
In turn, increased NF KappaB expression in the endomet-
rium may negatively influence implantation. For example,
overexpression of NF KappaB in the endometrium of in-
fertile patients with hydrosalpinx may lead to the recruit-
ment of excessive numbers of inflammatory cells and
stimulate the production of proinflammatory mediators
such as IL-1, IL-6, IL-8 and TNF-α, thus leading to exces-
sive inflammatory and immune responses in the endomet-
rium during the peri-implantation window, which mayinhibit or reduce embryo implantation. However, the exact
mechanisms by which NF KappaB affects implantation in
women with hydrosalpinx require further investigation.
MUC1, an important member of the mucin family, is a
highly glycosylated macromolecule. When at high levels
expressed on the cell surface, MUC1 can interfere with
cellular adhesion via a steric hindrance phenomenon.
Therefore, MUC1 may prevent adherence of the blasto-
cyst to the endometrium by acting as an anti-adhesion
molecule. The expression of MUC1 normally reduces
during implantation in other species [20]; however,
MUC1 is upregulated in the human endometrium dur-
ing the peri-implantation period [21]. Furthermore, both
MUC1 mRNA and protein expression increase several-
fold from the proliferative phase to the mid-secretory
phase [22]. It has been suggested that the repellent effect
of MUC-1 could be of importance in guiding the blasto-
cyst to the precise area fittest for implantation. Signifi-
cantly reduced expression of MUC1 can also affect the
embryo selection function of endometrium, subsequently
increasing the miscarriage rate or reducing the implant-
ation rate [23]. MUC1, an important implantation-
related immune factor in the endometrium, is also
expressed on the surface of T cells where it acts as an
immunomodulator. In this study, we observed that
MUC1 was significantly downregulated in the endomet-
rium of infertile patients with hydrosalpinx. This result is
partially in agreement with research by Li et al. [14], who
reported that MUC1 expression was significantly reduced
in the endometrium during the peri-implantation in
patients with hydrosalpinx. Low levels of MUC1 could
damage the embryo selection function of the endomet-
rium in infertile patients with hydrosalpinx, thus increas-
ing the miscarriage rate or reducing the implantation
rate [23]. Furthermore, our study also indicated a trend
towards increased MUC1 mRNA and protein expression
throughout the menstrual cycle, suggesting that MUC1 is
hormonally regulated during the menstrual cycle.
Interestingly, we observed a positive correlation be-
tween CFTR and MUC1 mRNA and a negative correl-
ation between CFTR and NF KappaB mRNA in the
endometrium of infertile women. This indicates that
CFTR can affect implantation in the endometrium not
only by functioning as an anion channel, but also by act-
ing as a molecular regulator. Previous studies have sug-
gested a relationship between the expression of CFTR
and MUC1 or NF KappaB [7,8,24]. Kuver et al.
described lower MUC1 expression in cftr (−/−) cells
compared to wild-type cells [8]. Hunter et al. indicated
that repression of NF KappaB signaling is normally
mediated by CFTR (7). Moreover, Chen et al. observed a
similar negative correlation between CFTR and NF
KappaB expression in lung cells, and proposed that a
functional negative regulation loop exists between these
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we tentatively suggest that CFTR may positively regulate
MUC1 in the endometrium, and negatively regulate NF
KappaB (and possibly other factors) in the endometrium,
via unknown mechanisms. It is possible that CFTR, as a
chloride channel, may affect the chloride concentration
in the cell, which may activate signaling pathways such
as the WNK-OSR1/SPAK pathway. CFTR is also known
to be either directly or indirectly involved in bicarbonate
transport, which is important for pH regulation [25].
The ability of CFTR to alter pH and ion concentrations
suggests that it plays a key role in the maintenance of
cellular homoeostasis. Decreased CFTR expression may
disrupt the cellular microenvironment and thus affect a
number other factors; however, the possible role of
CFTR in these processes and its ability to regulate
MUC1 and NF KappaB in the endometrium require fur-
ther investigation.
This study has some limitations, as we did not limit
patient selection to the implantation window. The pre-
cise expression levels and role of CFTR, MUC1 and NF
KappaB during the implantation window in infertile
patients with hydrosalpinx remain to be explored.Conclusions
This study demonstrates that the expression of NF
KappaB is significantly increased, while the expression of
CFTR and MUC1 are significantly decreased in the
endometrium of infertile patients with hydrosalpinx.
These results support the molecular mechanism hypoth-
esis for the regulation of endometrial receptivity in infer-
tile patients with hydrosalpinx. Moreover, the expression
of CFTR mRNA in the endometrium of patients with
hydrosalpinx correlates with the expression of both NF
KappaB and MUC1 mRNA. The specific association of
these factors with hydrosalpinx-associated impaired im-
plantation and the potential mechanisms underlying the
association between CFTR and other implantation bio-
markers await further investigation.Abbreviations
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